Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rizza

Showing results (111-120 of 314) with videos related to

Pageof 32
Sort By:
Diabetes|June 28, 2000
Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetesA Vella, P Shah, R Basu, et al.
Diabetes Care|February 7, 2009
Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolismAnanda Basu, Chiara Dalla Man, Rita Basu, et al.
Plos One|February 28, 2009
HIV induces TRAIL sensitivity in hepatocytesChallagundla K Babu, Kanitta Suwansrinon, Gary D Bren, et al.
Diabetes|October 29, 1998
Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptakeM F Nielsen, R Basu, S Wise, et al.
Endocrinology, Diabetes & Metabolism|April 15, 2021
Chromogranin A-positive hormone-negative endocrine cells in pancreas in human pregnancyAbu Saleh Md Moin, Kylie Zeng, Robert A Rizza, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1991
The nocturnal increase in growth hormone is not the cause of the nocturnal increase in serum osteocalcinP R Ebeling, P C Butler, R Eastell, et al.
The Journal of Clinical Endocrinology and Metabolism|July 19, 2018
Paradigm Shifts in Nocturnal Glucose Control in Type 2 DiabetesAnanda Basu, Nisha Joshi, John Miles, et al.
The Journal of Clinical Investigation|May 1, 1986
Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissuesR G Firth, P M Bell, H M Marsh, et al.
Mayo Clinic Proceedings|June 1, 1986
Effect of a purified amylase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes mellitusP Layer, R A Rizza, A R Zinsmeister, et al.
The Journal of Clinical Endocrinology and Metabolism|November 30, 2000
Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitusP Shah, A Vella, A Basu, et al.
Pageof 32

Showing results (111-120 of 314) with videos related to

Sort By:
Pageof 32
Diabetes|June 28, 2000
Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetesA Vella, P Shah, R Basu, et al.
Diabetes Care|February 7, 2009
Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolismAnanda Basu, Chiara Dalla Man, Rita Basu, et al.
Plos One|February 28, 2009
HIV induces TRAIL sensitivity in hepatocytesChallagundla K Babu, Kanitta Suwansrinon, Gary D Bren, et al.
Diabetes|October 29, 1998
Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptakeM F Nielsen, R Basu, S Wise, et al.
Endocrinology, Diabetes & Metabolism|April 15, 2021
Chromogranin A-positive hormone-negative endocrine cells in pancreas in human pregnancyAbu Saleh Md Moin, Kylie Zeng, Robert A Rizza, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1991
The nocturnal increase in growth hormone is not the cause of the nocturnal increase in serum osteocalcinP R Ebeling, P C Butler, R Eastell, et al.
The Journal of Clinical Endocrinology and Metabolism|July 19, 2018
Paradigm Shifts in Nocturnal Glucose Control in Type 2 DiabetesAnanda Basu, Nisha Joshi, John Miles, et al.
The Journal of Clinical Investigation|May 1, 1986
Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissuesR G Firth, P M Bell, H M Marsh, et al.
Mayo Clinic Proceedings|June 1, 1986
Effect of a purified amylase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes mellitusP Layer, R A Rizza, A R Zinsmeister, et al.
The Journal of Clinical Endocrinology and Metabolism|November 30, 2000
Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitusP Shah, A Vella, A Basu, et al.
Pageof 32